Investor Presentaiton

Infectious titre TU/mL) 1.0E+09 Lenti VV Stable Platform Delivers Consistent High Yields for Therapeutically Relevant Genes 1.0E+08 1.0E+07 1.0E+06 GFP Lenti VV Packaging cell line productivity with therapeutically relevant GOls shRNA T Factor VIII CAR-CD19 Infectious titre TU/mL 1.E+06 1.E+07 1.E+08 1.E+09 Neg GFP shRNA Lenti VV Producer pool productivity with therapeutically relevant GOIs CAR-CD19 CAR-BCMA PKLR Cas9 Stag2Cas9 FANCA Factor VIII ? Wuxi AppTec 药明康德

View entire presentation